732 results on '"Brioli A"'
Search Results
2. Pomalidomide combinations are a safe and effective option after daratumumab failure
3. Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma
4. A digital twin model for evidence-based clinical decision support in multiple myeloma treatment
5. Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial
6. P960: EXTRAMEDULLARY MYELOMA REMAINS AN UNMET CLINICAL NEED EVEN IN THE ERA OF NOVEL AGENT. ANALYSIS OF THE SINGLE CENTER MCOHORT.
7. Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialResearch in context
8. Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling
9. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
10. Immune Checkpoint Blockade
11. Cancer Immunotherapy
12. Diálogos interdisciplinares 2
13. COLABORAÇÃO ENTRE PROFESSORES DE EDUCAÇÃO FÍSICA VIA REDES DE DIÁLOGOS
14. Ascensão da utilização da fonte fotovoltaica residencial no estado de São Paulo
15. Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients
16. A digital twin model for evidence-based clinical decision support in multiple myeloma treatment
17. Preclinical safety evaluation of the aqueous extract from Mangifera indica Linn. (Anacardiaceae): genotoxic, clastogenic and cytotoxic assessment in experimental models of genotoxicity in rats to predict potential human risks
18. Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
19. Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)
20. The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML
21. Treatment of Transplant Eligible Patients with Multiple Myeloma
22. Unterschiede durch sozioökomische Benachteiligung, genetischen Hintergrund und Geschlecht bei Tumorerkrankungen
23. A digital twin model for evidence-based clinical decision support in multiple myeloma treatment.
24. P960: EXTRAMEDULLARY MYELOMA REMAINS AN UNMET CLINICAL NEED EVEN IN THE ERA OF NOVEL AGENT. ANALYSIS OF THE SINGLE CENTER MCOHORT.
25. Cancer Immunotherapy
26. The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey
27. Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma
28. Aqueous extract from Mangifera indica Linn. (Anacardiaceae) leaves exerts long-term hypoglycemic effect, increases insulin sensitivity and plasma insulin levels on diabetic Wistar rats.
29. Unterschiede durch sozioökomische Benachteiligung, genetischen Hintergrund und Geschlecht bei Tumorerkrankungen
30. Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications
31. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
32. Suppression of <scp>MYC</scp> by <scp>PI3K</scp> / <scp>AKT</scp> / <scp>mTOR</scp> pathway inhibition in combination with all‐trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia
33. Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling
34. ESTRUTURA FUNDIÁRIA E USO DA TERRA EM MATO GROSSO DO SUL
35. Supplementary Tables 1 and 2 from PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
36. Data from PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma
37. Pomalidomide combinations are a safe and effective option after daratumumab failure
38. Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
39. Treatment of Transplant Eligible Patients with Multiple Myeloma
40. Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
41. Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations
42. Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma
43. Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry
44. Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
45. Treatment and disease characteristics of chronic myeloid leukemia in blast crisis: the European Leukemianet Blast Crisis Registry [Abstract]
46. Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML
47. Multiples Myelom: Ixazomib, Daratumumab und niedrig dosiertes Dexamethason bei gebrechlichen Patienten
48. P-212: Quantifying the average treatment effect of single vs. tandem autologous stem cell transplantation in newly diagnosed multiple myeloma using causal inference
49. Biology and Treatment of Myeloma
50. Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.